DENALI THERAPEUTICS IN
29.35
07-十一月-24 14:32:09
15 分钟延时
股票
-0.20
-0.68%
今日范围
29.02 - 31.41
ISIN
N/A
来源
NASDAQ
-
Denali Therapeutics Announces FDA Clinical Hold on DNL919 Investigational New Drug (IND) Application
13 1月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
10 1月 2022 08:00:03 条件 Nasdaq GlobeNewswire
-
17 11月 2021 08:30:00 条件 Nasdaq GlobeNewswire
-
Denali Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights
04 11月 2021 16:01:00 条件 Nasdaq GlobeNewswire
-
06 10月 2021 16:01:00 条件 Nasdaq GlobeNewswire
-
Denali Therapeutics Appoints Katie Peng as Chief Commercial Officer
27 9月 2021 09:00:00 条件 Nasdaq GlobeNewswire
-
Denali Therapeutics Announces Initiation of Phase 1b Study of EIF2B Activator DNL343 in ALS
09 9月 2021 09:00:01 条件 Nasdaq GlobeNewswire
-
Denali Therapeutics Announces Publication in Cell on New Approach to Treat FTD-GRN
26 8月 2021 11:00:00 条件 Nasdaq GlobeNewswire
-
25 7月 2021 11:05:00 条件 Nasdaq GlobeNewswire
-
15 7月 2021 09:00:01 条件 Nasdaq GlobeNewswire
-
28 6月 2021 08:00:00 条件 Nasdaq GlobeNewswire
-
Denali Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
03 5月 2021 08:30:00 条件 Nasdaq GlobeNewswire
-
11 3月 2021 08:30:00 条件 Nasdaq GlobeNewswire
-
Denali Therapeutics Reports Full Year 2020 Financial Results and Business Highlights
25 2月 2021 16:01:01 条件 Nasdaq GlobeNewswire
-
12 2月 2021 07:30:00 条件 Nasdaq GlobeNewswire
-
05 2月 2021 09:00:00 条件 Nasdaq GlobeNewswire
-
Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors
11 1月 2021 08:30:00 条件 Nasdaq GlobeNewswire
-
08 1月 2021 08:30:00 条件 Nasdaq GlobeNewswire